Pandemic Influenza
📧 Sign up to get email alerts when something new happens for Pandemic Influenza.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-30Clinical Trial Results: A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine in Healthy Adults [Phase 1]
Phase 1 trial report on safety and immunogenicity of an intranasal nanoemulsion adjuvanted recombinant pandemic influenza vaccine in healthy…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults [Phase 1]
A Phase 1 clinical trial evaluating the quadrivalent influenza HA stem vaccine VRC-FLUMOS0122-00-VP (SteMos1) with and without ALFQ adjuvant…
-
EMA approval · 2025-12-17EMA Authorised: Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) (split influenza virus, inactivated, containing antigen: A/VietNam/1194/2004 (H5N1) like strain used (NIBRG-14)) — GlaxoSmithKline Biologicals S.A.
EMA authorised Adjupanrix, a split-virion inactivated adjuvanted influenza vaccine for pandemic influenza (H5N1) using the A/VietNam/1194/20…
-
CLINICAL_TRIALS trial_result · 2024-08-22Clinical Trial Update: A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine in Healthy Adults [Phase 1]
Phase 1 trial assessing safety and immune response of an intranasal nanoemulsion-adjuvanted recombinant pandemic influenza vaccine in health…
-
CLINICAL_TRIALS trial_result · 2020-02-11Clinical Trial Update: Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age [Phase 3]
Phase 3 trial updating immunogenicity, safety, and tolerability of adjuvanted and non-adjuvanted swine-origin H1N1 influenza vaccine in heal…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects From 6 Months to 17 Years of Age [Phase 3]
Phase 3 trial update reporting on immunogenicity, safety and tolerability of two doses of adjuvanted and non-adjuvanted swine-origin A/H1N1 …
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: Immunogenicity, Tolerability and Safety of One or Two Doses of an Adjuvanted Swine-origin A H1N1 Influenza Vaccine in Healthy Subjects 18 or More Years of Age Both Vaccinated and Not Yet Vaccinated Against Seasonal Influenza 2009/10 [Phase 2]
Phase 2 study assessing the immunogenicity, tolerability, and safety of one or two doses of an adjuvanted swine-origin H1N1 influenza vaccin…
-
CLINICAL_TRIALS trial_result · 2015-10-09Clinical Trial Update: A/H1N1 Immunogenicity and Safety in Adults [Phase 1, Phase 2]
Phase 1/2 clinical trial completed evaluating the immunogenicity and safety of an A/H1N1 influenza vaccine candidate in adults.
-
CLINICAL_TRIALS trial_result · 2015-10-09Clinical Trial Update: A/H1N1 Immunogenicity and Safety in Infants, Children and Adolescents [Phase 1, Phase 2]
Phase 1/2 clinical trial assessing the immunogenicity and safety of an A/H1N1 influenza vaccine in infants, children, and adolescents; the t…
-
CLINICAL_TRIALS research · 2015-10-09Clinical Trial Update: Observational Study to Assess Safety of H1N1 Pandemic Influenza Vaccine
Observational study update assessing safety of the H1N1 pandemic influenza vaccine; the study is completed.
-
CLINICAL_TRIALS research · 2015-10-09Clinical Trial Update: Phase 1 Study of a H5N1 Influenza Vaccine (Reverse Genetic Reassortant) [Phase 1]
Phase 1 study of an H5N1 influenza vaccine using reverse genetic reassortant has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-13Clinical Trial Update: A/H5N1/LT Dose Ranging Study [Phase 2]
Phase 2 dose-ranging trial of an H5N1 influenza vaccine completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-01-14Clinical Trial Update: Study of Swine-Origin A/H1N1 Influenza Non-Adjuvanted Vaccine in Healthy Adults in India [Phase 3]
Phase 3 study evaluating a swine-origin A/H1N1 influenza non-adjuvanted vaccine in healthy adults in India has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-14Clinical Trial Update: Safety and Immunogenicity of H5N1 Adjuvanted, Inactivated, Split-Virion Pandemic Influenza Vaccine in Healthy Adults [Phase 1]
Phase 1 trial evaluating safety and immune response of an adjuvanted H5N1 inactivated, split-virion influenza vaccine in healthy adults.
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Safety, Reactogenicity and Immunogenicity of an H5N1 VLP [Phase 1, Phase 2]
This clinical trial update reports safety, reactogenicity, and immunogenicity results for Novavax's H5N1 virus-like particle vaccine evaluat…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Immunogenicity, Safety and Tolerability of Prepandemic Influenza and Seasonal Influenza Vaccine in Adult Subjects [Phase 2]
Phase 2 trial evaluating the immunogenicity, safety and tolerability of a prepandemic and seasonal influenza vaccine in adults; results were…
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Safety, Tolerability and Immunogenicity of Two Doses of Adjuvanted Monovalent Influenza Vaccine Administered to Healthy Adult and Elderly Subjects [Phase 3]
Phase 3 trial update evaluating safety, tolerability, and immunogenicity of two doses of an adjuvanted monovalent influenza vaccine in healt…
-
CLINICAL_TRIALS withdrawal · 2012-04-24Clinical Trial Update: A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Volunteers Who Receive Long-term Prophylaxis Against Pandemic Influenza: PIPET B
This clinical trial to assess the effectiveness and safety of neuraminidase inhibitors for long-term prophylaxis against pandemic influenza …
-
CLINICAL_TRIALS withdrawal · 2012-04-24Clinical Trial Update: A Prospective Study to Examine the Effectiveness and Safety of Antivirals in Volunteers Who Receive Short-term Prophylaxis Against Pandemic Influenza
The study evaluating antivirals for short-term prophylaxis against pandemic influenza has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2011-10-12Clinical Trial Update: Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine (Egg-Derived) in Healthy Subjects From 6 Months to 17 Years of Age [Phase 3]
This Phase 3 trial evaluated the immunogenicity, safety, and tolerability of two-dose regimens of adjuvanted and non-adjuvanted swine-origin…
-
CLINICAL_TRIALS trial_result · 2011-10-05Clinical Trial Update: Observational Safety Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine
This completed observational safety study evaluated the safety of an adjuvanted Swine Origin A(H1N1) pandemic subunit egg-derived vaccine.
-
EMA guidance · 2010-01-22European Medicines Agency updates on pandemic influenza
EMA provides updates and guidance related to pandemic influenza, including regulatory considerations, vaccine development timelines, and sta…
-
CLINICAL_TRIALS trial_result · 2007-11-09Clinical Trial Update: Safety and Immunogenicity of an Inactivated Pandemic Influenza Vaccine [Phase 2]
This Phase 2 trial reports safety and immunogenicity data for an inactivated pandemic influenza vaccine.